• Glaukos, Avedro Announce Acquisition Agreement americanpharmaceuticalreview
    August 12, 2019
    Glaukos and Avedro announced the companies have entered into a definitive merger agreement under which Glaukos will acquire Avedro in an all-stock transaction. The transaction, which is subject to Avedro stockholder approval along with
  • Santen, Glaukos collaborate for exclusive distribution of the MicroShunt in the U.S. biospectrumasia
    April 29, 2019
    The agreement stipulates that upon potential U.S. regulatory approval, Glaukos will be the exclusive distributor of the MicroShunt in the United States, responsible for sales and distribution of the product.
PharmaSources Customer Service